Skip to main content
Log in

The management of peritoneal surface malignancy of colorectal cancer origin

  • Published:
Techniques in Coloproctology Aims and scope Submit manuscript

Abstract

Colorectal carcinomas are predominantly spread malignancies. Peritoneal carcinomatosis frequently associates colorectal carcinomas. The tumour grade, the completeness of cytoreduction, the tumour volume, the presence of distant metastases, prior surgery score and the extent of peritoneal implantations are prognostic clinical features of survival. The management of colorectal cancer with peritoneal carcinomatosis is possible by resection of tumour, cytoreduction and intraperitoneal chemotherapy. T3 and T4 colorectal tumours are at risk of developing locoregional recurrence and may be treated by intraperitoneal chemotherapy. Early postoperative intraperitoneal chemotherapy has been used in 40 patients with T3 and T4 tumours, with 15% hospital mortality, and 32.5% morbidity. The overall 3-year survival rate was over 80% and only 15% distant metastases were recorded.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. A. K. Tentes.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tentes, A.A.K. The management of peritoneal surface malignancy of colorectal cancer origin. Tech Coloproctol 8 (Suppl 1), s39–s42 (2004). https://doi.org/10.1007/s10151-004-0107-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10151-004-0107-z

Key words

Navigation